LADENBURG THALMANN FINANCIAL SERVICES INC. - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 45 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2020. The put-call ratio across all filers is 35.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q4 2019$7,000
+250.0%
2,4000.0%0.00%
Q3 2019$2,0000.0%2,4000.0%0.00%
Q2 2019$2,000
-33.3%
2,4000.0%0.00%
Q1 2019$3,0000.0%2,4000.0%0.00%
Q4 2018$3,000
-80.0%
2,4000.0%0.00%
Q3 2018$15,000
-42.3%
2,4000.0%0.00%
Q2 2018$26,0000.0%2,4000.0%0.00%
Q1 2018$26,000
+85.7%
2,400
+20.0%
0.00%
Q4 2017$14,0002,0000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q1 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 3,750,107$10,875,0000.41%
Plante Moran Financial Advisors, LLC 50,000$145,0000.05%
Donald L. Hagan, LLC 14,000$40,0000.04%
Game Plan Financial Advisors, LLC 11,000$32,0000.03%
Tekla Capital Management LLC 165,330$479,0000.02%
Virtu Financial LLC 52,655$153,0000.02%
SIGNATUREFD, LLC 58,326$169,0000.01%
OXFORD ASSET MANAGEMENT LLP 131,783$382,0000.01%
Lindbrook Capital, LLC 10,000$29,0000.01%
WEDBUSH SECURITIES INC 40,700$118,0000.01%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders